Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Hematological Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06757829
What this trial is testing

Pulmonary Functions in Sickle Cell Disease: Response to Acu-TENS

Who this might be right for
Sickle Cell Disease
Cairo University 40
Large-scale testing (Phase 3)Study completedNCT05253781
What this trial is testing

Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE)

Who this might be right for
Intrauterine Growth RestrictionPreeclampsiaSickle Cell Disease+1 more
University of Lagos, Nigeria 476
Not applicableLooking for participantsNCT07826845
What this trial is testing

Body Donation in HHT

Who this might be right for
Hereditary Hemorrhagic Telangiectasia
University Hospital, Essen 5
Not applicableStudy completedNCT03741881
What this trial is testing

A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)

Who this might be right for
Haemophilia AHaemophilia A With InhibitorsHaemophilia B+1 more
Novo Nordisk A/S 231
Testing effectiveness (Phase 2)Study completedNCT00229619
What this trial is testing

Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia

Who this might be right for
Anemia, AplasticRed-Cell Aplasia, PureAnemia, Diamond-Blackfan
National Heart, Lung, and Blood Institute (NHLBI) 11
Not applicableNot Yet RecruitingNCT07653139
What this trial is testing

Patient Preferences in Treatment of Haemophilia A With and Without Inhibitors: a Discrete Choice Experiment in Germany

Who this might be right for
Haemophilia A
Novo Nordisk A/S 150
Not applicableApproved For MarketingNCT03154437
What this trial is testing

An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors

Who this might be right for
Hemophilia A
Genentech, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT04248439
What this trial is testing

Gene Therapy for Fanconi Anemia, Complementation Group A

Who this might be right for
Fanconi Anemia Complementation Group A
Rocket Pharmaceuticals Inc. 5
Early research (Phase 1)Study completedNCT00003107
What this trial is testing

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Indiana University
Testing effectiveness (Phase 2)Study completedNCT03041909
What this trial is testing

An Extension Study to Further Evaluate the Safety, Tolerability of GBT440 in Patients With Sickle Cell Disease Who Participated in the Study GBT440-001

Who this might be right for
Sickle Cell Disease
Global Blood Therapeutics 5
Not applicableStudy completedNCT03462511
What this trial is testing

Hydroxyurea Adherence for Personal Best in Sickle Cell Disease (HABIT): Efficacy Trial

Who this might be right for
Sickle Cell Disease
Columbia University 50
Testing effectiveness (Phase 2)Study completedNCT02797964
What this trial is testing

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
Sierra Oncology LLC - a GSK company 107
Large-scale testing (Phase 3)Study completedNCT02973087
What this trial is testing

RVWF IN PROPHYLAXIS

Who this might be right for
Von Willebrand Disease
Takeda 29
Not applicableLooking for participantsNCT06887907
What this trial is testing

Phenotypic and Transcriptomic Description of Megakaryocytes in Sickle Cell Patient

Who this might be right for
Sickle Cell Disease (SCD)
University Hospital, Toulouse 40
Not applicableLooking for participantsNCT07776444
What this trial is testing

Cerebrovascular Reactivity Measurements With High-Density Diffuse Optical Tomography

Who this might be right for
Sickle Cell DiseaseCerebral Stroke
Washington University School of Medicine 120
Early research (Phase 1)Study completedNCT01708564
What this trial is testing

A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B

Who this might be right for
Hemophilia
rEVO Biologics 15
Not applicableStudy completedNCT01322165
What this trial is testing

National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions

Who this might be right for
Marfan SyndromeTurner SyndromeEhlers-Danlos Syndrome+9 more
National Heart, Lung, and Blood Institute (NHLBI) 3,706
Early research (Phase 1)Study completedNCT00744692
What this trial is testing

Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders

Who this might be right for
Non Malignant DisordersImmunodeficienciesCongenital Marrow Failures+5 more
Duke University 22
Not applicableEnrolling By InvitationNCT07527975
What this trial is testing

Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the Infusion of RP-L102

Who this might be right for
Fanconi Anemia
Rocket Pharmaceuticals Inc. 14
Not applicableWithdrawnNCT01051544
What this trial is testing

Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive

Who this might be right for
Severe Hemophilia A
City of Hope Medical Center
Next Page